Impact of Trismus on Quality of Life in Head and Neck Cancer Survivors
Overview
This study investigates the prevalence of trismus in head and neck cancer survivors up to a decade after completing radiotherapy.
Background
Head and neck cancer (HNC) represents a considerable global health burden, with increasing incidence rates. Long-term survivors often face complications such as trismus, which can impair quality of life.
Data Highlights
No numerical data provided in the source material.
Key Findings
Trismus affects approximately 33% of head and neck cancer survivors 3–10 years after radiotherapy.
Trismus is associated with pain, eating limitations, and reduced oral hygiene ability.
Health-related quality of life (HRQL) is significantly impacted by the presence of trismus.
Long-term HRQL trajectories indicate that certain symptoms may worsen over time post-treatment.
Prospective studies have not previously examined HRQL or trismus beyond 5 years after treatment completion.
Clinical Implications
Healthcare providers should assess for trismus in head and neck cancer survivors, particularly those who have completed radiotherapy.
Conclusion
Trismus is a prevalent complication for head and neck cancer survivors long after treatment.
